DHX37

Across TCGA pan-cancer cohorts, DHX37 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of DHX37’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where DHX37 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types DHX37 is over-expressed in tumor.

CCRCC, LSCC, and LUAD are the cancer types where DHX37 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DHX37 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Female	II,III,IV	+0.224	<.001	12	view →
LSCC	Male	II,III,IV	+0.405	<.001	9	view →
LUAD	Male	All	+0.194	<.001	8	view →
HNSC	All	III,IV	+0.138	<.001	7	view →
COAD	Male	All	+0.314	<.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

DHX37–CCRCC

Open the CCRCC breakdown →